|
|
|
|
Дата |
|---|
| 25.06.2026 |
| 24.06.2026 |
| 23.06.2026 |
| 22.06.2026 |
| 21.06.2026 |
| 18.06.2026 |
| 16.06.2026 |
| 15.06.2026 |
| 14.06.2026 |
| 11.06.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
88.48
|
86.70
|
88.70
|
88.50
|
|
|
9 246 790.03
|
239.00
|
|
|
|
87.37
|
86.02
|
88.50
|
88.48
|
|
|
13 568 223.83
|
261.00
|
|
|
|
89.70
|
87.22
|
89.99
|
87.37
|
|
|
9 470 300.02
|
271.00
|
|
|
|
89.00
|
87.95
|
89.80
|
89.70
|
|
|
19 018 474.62
|
504.00
|
|
|
|
84.20
|
84.51
|
89.47
|
89.00
|
|
|
175 066 472.47
|
1 323.00
|
|
|
|
84.00
|
83.80
|
84.50
|
84.20
|
|
|
6 188 265.89
|
219.00
|
|
|
|
84.02
|
83.50
|
84.50
|
84.00
|
|
|
12 886 326.85
|
466.00
|
|
|
|
84.50
|
83.02
|
85.01
|
84.02
|
|
|
20 279 238.77
|
563.00
|
|
|
|
84.58
|
84.00
|
86.50
|
84.50
|
|
|
20 298 880.59
|
666.00
|
|
|
|
85.51
|
83.02
|
85.50
|
84.58
|
|
|
13 108 930.62
|
593.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
26.04.2026
|
27.04.2026 |
3.5 EGP |
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
